Huperzine
Best for
Sharpen focus and mental stamina
Likely strong benefit for 8 weeks · 2 studies , n=130
8 papers · 3 claims · 22 outcomes scored · 3 positive
Outcomes
What huperzine actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
Concentrate longer, resist distraction, and stay mentally sharp through demanding tasks.
Memory, attention, and orientation hold up longer before fading.
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Sharpen focus and mental stamina Likely strong benefit | | 2 RCTs n=130 | 0.2–200 mg | 8 wk | #1/40 |
| Slow cognitive decline in dementia Likely benefit | | 6 meta-analyses n=8.7k Meta-analyzed | 0.2–400 mg | 8–26 wk | #2/23 |
| Strengthen your memory Likely modest benefit | | 2 meta-analyses n=209 Meta-analyzed | 0.2–200 mg | 8 wk | #7/42 |
Recommended Huperzine products
Real products that dose Huperzine where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.
-
Nootropics Depot
Huperzine A 1%
Well dosed 200 mcg/day A formulaBrand audit 87/100
-
Life Extension
Huperzine A 200 mcg
Well dosed 400 mcg/day B formulaBrand audit 90/100
-
Swanson
Huperzine A 200 mcg
Well dosed 200 mcg/day A formulaBrand audit 69/100
-
Nutricost
Huperzine-A 200 mcg
Well dosed 200 mcg/day A formulaBrand audit 57/100
-
Source Naturals
Huperzine A 100 mcg
Well dosed 200 mcg/day B formulaBrand audit 73/100
-
Source Naturals
Huperzine A 200 mg
Well dosed 400 mcg/day B formulaBrand audit 73/100
Chosen for adequate Huperzine dosing vs. the studied range, a clean formulation (grade A–C), and independent brand-quality audits. Not sponsored.
Risk profile
Adverse events and known drug interactions
Safety events
Sources
- 1. A phase II trial of huperzine A in mild to moderate Alzheimer disease. (2011) ↑
- 2. Huperzine A for vascular dementia. (2009) ↑
- 3. Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials. (2013) ↑
- 4. Identification of the optimal cognitive drugs among Alzheimer's disease: a Bayesian meta-analytic review. (2018) ↑
- 5. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease. (2019) ↑
- 6. The effect of anti-dementia drugs on Alzheimer disease-induced cognitive impairment: A network meta-analysis. (2019) ↑
- 7. Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial. (2021) ↑
- 8. Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder. (2015) ↑
Generated August 14, 2026
Related
More evidence for Huperzine
Evidence map
Focus & memory
NewFocus & memory: evidence map across 45 supplements
Evidence coverage map
Jul 30, 2026
Ingredient evidence
Ingredient evidence
NewCholine
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewGinkgo
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewOmega-3
All scored outcomes
Aug 14, 2026
Systematic review
Systematic review
NewGinkgo Biloba for Cognitive Impairment and Dementia: A Systematic Evidence Review
GRADE evidence review
Apr 8, 2026
Ingredient evidence
Ingredient evidence
NewHericium mushroom
All scored outcomes
Aug 14, 2026